Drug Shortage Report for METHOTREXATE SUBCUTANEOUS

Last updated on 2023-04-15 History
Report ID 181027
Drug Identification Number 02491311
Brand name METHOTREXATE SUBCUTANEOUS
Common or Proper name METHOTREXATE SUBCUTANEOUS
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 15MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-13
Estimated end date 2023-04-14
Actual end date 2023-04-13
Shortage status Resolved
Updated date 2023-04-15
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-04-15 French Compare
v12 2023-04-15 English Compare
v11 2023-03-20 French Compare
v10 2023-03-20 English Compare
v9 2023-03-20 French Compare
v8 2023-03-20 English Compare
v7 2023-03-14 French Compare
v6 2023-03-14 English Compare
v5 2023-02-13 French Compare
v4 2023-02-13 English Compare
v3 2023-01-14 English Compare
v2 2023-01-13 French Compare
v1 2023-01-13 English Compare

Showing 1 to 13 of 13